Tamiflu Lower Dose Capsules Clear FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Low-dose capsules provide an alternative influenza treatment for children ages one and older and have a longer shelf life than liquid suspension, Roche says.
You may also be interested in...
Roche To Tailor Tamiflu Production As Supply Is Ample To Meet Demand
Supply of the antiviral significantly exceeds current orders for pandemic planning, Roche reports.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.
CinFina Pushes Early Work In Obesity In Hopes Of A Deal
Emerging Company Profile: CinFina is advancing two novel mechanisms of action in obesity as monotherapies and in combination with GLP-1s.